SynthesisImmunologic research2026
Effectiveness and safety of ravulizumab in anti-acetylcholine receptor antibody-positive (AChR-Ab+) generalized myasthenia gravis: a systematic review and meta-analysis.
Haneen Sabet et al.PubMed ↗Publisher ↗
No numbers read from the abstract.